Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS)

NSE:AKUMS Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	16,091	3,860	1,012	1,111	516.08	551.39
Short-Term Investments	708.54	12,946	4,671	1,660	983.81	477.08
Cash & Short-Term Investments	16,800	16,806	5,683	2,771	1,500	1,028
Cash Growth	1.54%	195.72%	105.13%	84.72%	45.84%	18.38%
Accounts Receivable	8,595	7,966	7,703	8,338	8,451	8,843
Other Receivables	-	-	-	-	114.05	-
Receivables	8,595	7,966	7,703	8,338	8,639	8,843
Inventory	9,035	7,557	6,809	6,304	7,298	7,224
Prepaid Expenses	-	188.44	164.55	127.11	90.96	79.42
Other Current Assets	3,830	3,081	2,386	1,869	1,714	1,741
Total Current Assets	38,259	35,599	22,746	19,409	19,242	18,916
Property, Plant & Equipment	17,690	16,249	15,498	13,772	11,925	10,439
Long-Term Investments	1.43	1.75	2.92	1.43	77.76	136.99
Goodwill	20.63	20.63	20.63	20.63	20.63	20.63
Other Intangible Assets	105.81	62.09	83.03	68.85	59	56.4
Long-Term Deferred Tax Assets	1,339	1,709	2,081	1,231	315.17	188.53
Other Long-Term Assets	900.39	828.5	703.16	660.96	1,026	877.71
Total Assets	58,316	54,470	41,134	35,164	32,665	30,690

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	7,642	6,022	6,428	5,321	5,671	5,897
Accrued Expenses	-	1,038	798.71	763.05	564.96	633.68
Short-Term Debt	361.53	1,073	729.93	3,677	3,913	3,427
Current Portion of Long-Term Debt	-	-	-	455.63	339.25	66.86
Current Portion of Leases	76.19	76.33	72.3	57.65	72.41	66.22
Current Income Taxes Payable	163.9	89.25	4.01	14.35	187.68	478
Current Unearned Revenue	-	1,915	230.96	1.03	225.1	-
Other Current Liabilities	4,412	735.25	673.71	1,816	1,682	2,155
Total Current Liabilities	12,656	10,948	8,937	12,106	12,656	12,724
Long-Term Debt	-	-	-	782.97	1,155	133.33
Long-Term Leases	732.89	768.44	673.27	679.05	748.8	304.08
Long-Term Unearned Revenue	8,585	8,408	-	-	-	-
Pension & Post-Retirement Benefits	-	387.81	263.69	219.13	190.96	172.92
Long-Term Deferred Tax Liabilities	127.72	177.06	186.16	121.54	253.01	392.98
Other Long-Term Liabilities	981.85	469.5	437.72	14,051	10,428	10,711
Total Liabilities	23,083	21,158	10,498	27,959	25,432	24,439

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	306.21	306.21	306.21	286.13	286.13	143.07
Additional Paid-In Capital	-	10,942	10,840	1,272	1,272	1,272
Retained Earnings	-	20,856	18,294	6,308	6,385	5,576
Comprehensive Income & Other	34,722	1,030	1,030	-771.26	-771.26	-771.26
Total Common Equity	35,029	33,133	30,470	7,095	7,172	6,220
Minority Interest	204.23	177.73	165.97	109.88	61.85	31.95
Shareholders' Equity	35,233	33,311	30,636	7,205	7,234	6,252
Total Liabilities & Equity	58,316	54,470	41,134	35,164	32,665	30,690

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	1,171	1,917	1,476	5,652	6,229	3,998
Net Cash (Debt)	15,629	14,889	4,208	-2,882	-4,729	-2,969
Net Cash Growth	-0.08%	253.85%	-	-	-	-
Net Cash Per Share	102.07	97.25	28.12	-20.14	-33.05	-20.76
Filing Date Shares Outstanding	153.12	153.1	153.1	147.36	143.06	143.06
Total Common Shares Outstanding	153.12	153.1	153.1	143.06	143.06	143.06
Working Capital	25,603	24,651	13,809	7,303	6,586	6,192
Book Value Per Share	228.76	216.41	199.02	49.59	50.13	43.48
Tangible Book Value	34,902	33,051	30,366	7,006	7,092	6,143
Tangible Book Value Per Share	227.94	215.87	198.34	48.97	49.57	42.94
Land	-	416.93	416.93	416.93	337.15	336.4
Buildings	-	5,556	5,048	4,451	4,070	3,922
Machinery	-	15,999	14,659	12,251	10,618	9,665
Construction In Progress	-	1,767	1,596	1,951	1,030	308.19

Data Source: S&P Global Market Intelligence Last updated: Nov 2, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error